Nordson CapEx decreased by 41.9% to $10.18M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 36.5%, from $16.04M to $10.18M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 11.0% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.83M | $9.33M | $10.23M | $12.49M | $12.29M | $14.60M | $12.06M | $9.30M | $6.05M | $8.90M | $10.34M | $7.53M | $14.38M | $21.88M | $20.62M | $21.40M | $16.04M | $11.56M | $9.06M | $17.51M | $10.18M |
| QoQ Change | — | -13.8% | +9.6% | +22.1% | -1.6% | +18.8% | -17.4% | -22.8% | -35.0% | +47.1% | +16.2% | -27.2% | +90.9% | +52.2% | -5.7% | +3.8% | -25.0% | -27.9% | -21.7% | +93.3% | -41.9% |
| YoY Change | — | — | — | — | +13.5% | +56.5% | +17.8% | -25.5% | -50.8% | -39.1% | -14.2% | -19.0% | +137.8% | +146.0% | +99.5% | +184.2% | +11.6% | -47.2% | -56.1% | -18.2% | -36.5% |